microRNAs

Promising biomarkers and therapeutic targets of acute myocardial ischemia

Pasquale Fasanaro, Yuri D’Alessandra, Alessandra Magenta, Giulio Pompilio, Maurizio C. Capogrossi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

microRNAs (miRNAs), small non-coding RNA molecules that act as negative regulators of gene expression, are involved in a wide range of biological functions and control several cellular processes. This review illustrates miRNA regulation and function in tissue response to acute ischemia, focusing on miRNA role in acute myocardial infarction and describing a subset of miRNAs de-regulated upon cardiac ischemia. These miRNAs may represent “master ischemic” miRNAs, playing a pathogenetic role in one of the different components of tissue response to ischemia. Moreover, circulating miRNAs correlated to myocardial infarction and examples of miRNA involvement in ischemic diseases different from cardiac ischemia are also discussed. The identification of specific miRNAs as key regulators of cell biology has opened new clinical avenues, and may allow new diagnostic and/or prognostic tools development, as much as innovative therapeutic strategies. Two paradigmatic reports, in which miRNAs have been targeted to improve cardiac function in pre-clinical models of myocardial infarction, are described in detail and confirmed the efficacy of these strategies.

Original languageEnglish
Pages (from-to)305-315
Number of pages11
JournalCurrent Vascular Pharmacology
Volume13
Issue number3
Publication statusPublished - Jul 1 2015

Fingerprint

MicroRNAs
Myocardial Ischemia
Biomarkers
Ischemia
Therapeutics
Myocardial Infarction
Small Untranslated RNA
Regulator Genes
Cell Biology
Heart Diseases
Gene Expression

Keywords

  • Acute myocardial ischemia
  • Ischemic diseases
  • MicroRNAs
  • MiRNA-based therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

microRNAs : Promising biomarkers and therapeutic targets of acute myocardial ischemia. / Fasanaro, Pasquale; D’Alessandra, Yuri; Magenta, Alessandra; Pompilio, Giulio; Capogrossi, Maurizio C.

In: Current Vascular Pharmacology, Vol. 13, No. 3, 01.07.2015, p. 305-315.

Research output: Contribution to journalArticle

Fasanaro, Pasquale ; D’Alessandra, Yuri ; Magenta, Alessandra ; Pompilio, Giulio ; Capogrossi, Maurizio C. / microRNAs : Promising biomarkers and therapeutic targets of acute myocardial ischemia. In: Current Vascular Pharmacology. 2015 ; Vol. 13, No. 3. pp. 305-315.
@article{4d512bdc41c24612961d2ebc664c3718,
title = "microRNAs: Promising biomarkers and therapeutic targets of acute myocardial ischemia",
abstract = "microRNAs (miRNAs), small non-coding RNA molecules that act as negative regulators of gene expression, are involved in a wide range of biological functions and control several cellular processes. This review illustrates miRNA regulation and function in tissue response to acute ischemia, focusing on miRNA role in acute myocardial infarction and describing a subset of miRNAs de-regulated upon cardiac ischemia. These miRNAs may represent “master ischemic” miRNAs, playing a pathogenetic role in one of the different components of tissue response to ischemia. Moreover, circulating miRNAs correlated to myocardial infarction and examples of miRNA involvement in ischemic diseases different from cardiac ischemia are also discussed. The identification of specific miRNAs as key regulators of cell biology has opened new clinical avenues, and may allow new diagnostic and/or prognostic tools development, as much as innovative therapeutic strategies. Two paradigmatic reports, in which miRNAs have been targeted to improve cardiac function in pre-clinical models of myocardial infarction, are described in detail and confirmed the efficacy of these strategies.",
keywords = "Acute myocardial ischemia, Ischemic diseases, MicroRNAs, MiRNA-based therapy",
author = "Pasquale Fasanaro and Yuri D’Alessandra and Alessandra Magenta and Giulio Pompilio and Capogrossi, {Maurizio C.}",
year = "2015",
month = "7",
day = "1",
language = "English",
volume = "13",
pages = "305--315",
journal = "Current Vascular Pharmacology",
issn = "1570-1611",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - microRNAs

T2 - Promising biomarkers and therapeutic targets of acute myocardial ischemia

AU - Fasanaro, Pasquale

AU - D’Alessandra, Yuri

AU - Magenta, Alessandra

AU - Pompilio, Giulio

AU - Capogrossi, Maurizio C.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - microRNAs (miRNAs), small non-coding RNA molecules that act as negative regulators of gene expression, are involved in a wide range of biological functions and control several cellular processes. This review illustrates miRNA regulation and function in tissue response to acute ischemia, focusing on miRNA role in acute myocardial infarction and describing a subset of miRNAs de-regulated upon cardiac ischemia. These miRNAs may represent “master ischemic” miRNAs, playing a pathogenetic role in one of the different components of tissue response to ischemia. Moreover, circulating miRNAs correlated to myocardial infarction and examples of miRNA involvement in ischemic diseases different from cardiac ischemia are also discussed. The identification of specific miRNAs as key regulators of cell biology has opened new clinical avenues, and may allow new diagnostic and/or prognostic tools development, as much as innovative therapeutic strategies. Two paradigmatic reports, in which miRNAs have been targeted to improve cardiac function in pre-clinical models of myocardial infarction, are described in detail and confirmed the efficacy of these strategies.

AB - microRNAs (miRNAs), small non-coding RNA molecules that act as negative regulators of gene expression, are involved in a wide range of biological functions and control several cellular processes. This review illustrates miRNA regulation and function in tissue response to acute ischemia, focusing on miRNA role in acute myocardial infarction and describing a subset of miRNAs de-regulated upon cardiac ischemia. These miRNAs may represent “master ischemic” miRNAs, playing a pathogenetic role in one of the different components of tissue response to ischemia. Moreover, circulating miRNAs correlated to myocardial infarction and examples of miRNA involvement in ischemic diseases different from cardiac ischemia are also discussed. The identification of specific miRNAs as key regulators of cell biology has opened new clinical avenues, and may allow new diagnostic and/or prognostic tools development, as much as innovative therapeutic strategies. Two paradigmatic reports, in which miRNAs have been targeted to improve cardiac function in pre-clinical models of myocardial infarction, are described in detail and confirmed the efficacy of these strategies.

KW - Acute myocardial ischemia

KW - Ischemic diseases

KW - MicroRNAs

KW - MiRNA-based therapy

UR - http://www.scopus.com/inward/record.url?scp=84937142954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937142954&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 305

EP - 315

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

SN - 1570-1611

IS - 3

ER -